by Harvey Mogojwe | Jun 15, 2022
Osaka (Japan), Geneva (Switzerland), Boston (USA), June 15, 2022 – Shionogi & Co., Ltd. (Shionogi) and the Global Antibiotic Research and Development Partnership (GARDP) have today announced the execution of a license and technology transfer agreement and,...
by Corina Milic | May 16, 2022
Download the latest TA device prices Global health agency Unitaid and the Clinton Health Access Initiative (CHAI) today released results from a two-year project to increase access to lifesaving treatment for cervical precancer in low- and middle-income countries. The...
by Corina Milic | May 12, 2022
On May 12, 2022 CHAI announced agreements with leading generic manufacturers to make generic Paxlovid (nirmatrelvir/ritonavir – NIR/r) available to low- and middle income countries for under US$25 per treatment course. The announcement can be found here. How...
by Corina Milic | May 12, 2022
New agreements will make generic Paxlovid available at under US$25 per treatment course. Companies to dedicate capacity for 4.5 million treatment courses per month. The Clinton Health Access Initiative (CHAI) today announced agreements with leading generic...
by Scott Miller | Apr 14, 2022
For immediate release, April 14, 2022 — The Board of The Clinton Health Access Initiative (CHAI) is pleased to announce the appointment of Dr. Neil Buddy Shah as Chief Executive Officer of CHAI, succeeding interim co-CEOs Joy Phumaphi and Ann Veneman, who will remain...
by Harvey Mogojwe | Feb 21, 2022
We are devastated to learn of the passing of our beloved friend, colleague, and CHAI board member, Dr. Paul Farmer. Paul was a champion for the health of those in need. He was a pathfinder, a mentor, and a guide to thousands of health workers throughout the world...
